Target intelligence / Profile preview

60S ribosomal protein L21 (RPL21)

Target
RPL21
Molecular classification
Other, Ribosomal protein, Structural protein
01

Overview

60S ribosomal protein L21 is a structural component of the large (60S) subunit of cytoplasmic ribosomes, organelles responsible for catalyzing protein synthesis in cells[2][3][1]. RPL21 belongs to the L21E family of ribosomal proteins and primarily functions in translation as part of the ribosome. Beyond its canonical role, RPL21 (also known as eL21) demonstrates extra-ribosomal functions; for example, it interacts with the lysine methyltransferase SMYD2, influencing cell proliferation and potentially contributing to oncogenic processes when dysregulated[1][6]. Mutations in RPL21 are causative for hereditary hypotrichosis simplex, a non-syndromic form of hair loss[1][2][3][4]. There are currently no drugs known to directly target RPL21, and its use as a drug target is not established; rather, its significance is primarily in fundamental biology and as a disease gene in specific hereditary and potentially oncogenic contexts.

Other names
ribosomal protein L21eL21L21HYPT12FLJ27458MGC71252MGC104274MGC104275DKFZp686C0610160S ribosomal protein L21
02

Biological functions

Protein synthesis (translation)Structural constituent of ribosomeRNA bindingRegulation of cell proliferation (via extra-ribosomal roles)Possible regulation of transcription (via interaction with SMYD2)
03

Disease associations

Hypotrichosis simplex (hereditary hair loss disorder)Cancer (via modulation of cell proliferation and SMYD2 interaction)
04

Safety considerations

As a ribosomal protein, general inhibition could disrupt global protein synthesis and cause severe toxicity; targeted modulation is not established therapeutically
05

Biomarkers

Mutations in RPL21 as a biomarker for hereditary hypotrichosis simplex

Beyond the preview

Go deeper on 60S ribosomal protein L21 (RPL21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 60S ribosomal protein L21 (RPL21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call